Vimarsana
Biggest News Aggregation in the World

Page 14 - Alpha Wave News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Alpha Wave. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Alpha Wave Today - Breaking & Trending Today

Accel-backed Virgio pivots from fast-fashion to sustainable clothing - Vimarsana News

Accel-backed Virgio pivots from fast-fashion to sustainable clothing

The company does not need additional capital for its pivot. Most of the $37 million that Virgio raised last year remains in the company’s bank account and gives the company a cash runway of three years, per Nagaram.

Former Myntra CEO's Fashion Startup Virgio Pivots A Year After Raising $37 Mn - Vimarsana News

Former Myntra CEO's Fashion Startup Virgio Pivots A Year After Raising $37 Mn

Virgio, a fashion ecommerce set up by former Myntra CEO Amar Nagaram, will pivot from fast fashion to sustainable fashion.

Source: inc42.com
Related Topics:
Amar NagaramAlpha Wave
Two dozen investors to assess startup funding decks at VCCircle's 'The Pitch' in Delhi - Vimarsana News

Two dozen investors to assess startup funding decks at VCCircle's 'The Pitch' in Delhi

A set of around two dozen investors and their representatives shall go through elevator pitches made by a curated set of startups in the Delhi ......

Editor's take: The week that was — Sept 25-30 - Vimarsana News

Editor's take: The week that was — Sept 25-30

This week, the Indonesian government prohibited social commerce players from making direct transactions on social media platforms.

Avalyn's New Twist on Older Lung Disease Drugs Attracts $175M for Clinical Trials - Vimarsana News

Avalyn's New Twist on Older Lung Disease Drugs Attracts $175M for Clinical Trials

Avalyn Pharma aims to improve treatment of Idiopathic pulmonary fibrosis with inhalable versions of two older oral drugs and it’s now headed for mid-stage testing backed by a Series C financing. Other recent biotech industry financings raised money for research in cancer, immunology, and rare genetic diseases.